3
Views
0
CrossRef citations to date
0
Altmetric
Biotechnology & Immunology

Patent Evaluation: Oligonucleotide Inhibitors of HSV

Pages 679-680 | Published online: 02 Mar 2011
 

Summary

Novelty: Antisense oligomers which are complementary to vital regions of a viral genome or mRNA transcripts thereof, are disclosed. Methylphosphonate oligomers complementary to particular sequences of herpes simplex virus type 1 (HSV-1) mRNA are demonstrated to have antiviral activity. Methods of inhibiting viral replication using these oligomers are also provided.

Biology: In one aspect, the invention discloses a method of interfering with the replication of a virus after infection of host cells. The cells are contacted with an amount of oligomer which is complementary to, and which hybridizes with, a messenger RNA sequence for a gene essential in viral DNA synthesis and/or replication. For Herpes simplex viruses, the target sequence comprises an mRNA transcipt of an essential beta-gene. Suitable regions of these genes for selection of a target sequence include a sequence at, or proximate to, a 5′-translational start or a 3′-adenylation signal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.